Molecular testing for a panel of cancer susceptibility genes was undertaken (ATM, BRIP1, CHEK2, DICER1, MLH1, MSH1, MSH6, PMS2, RAD51C, RAD51D). This evidence concerns the gene PMS2 and cancer.